VT
CVS icon

Vise Technologies’s CVS Health CVS Stock Holding History

Vise Technologies’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.09M Buy
58,892
+24,741
+72% +$2.21M 0.07% 234
2026
Q1 		$2.71M Hold
34,151
– – 0.05% 290
2025
Q4 		$2.71M Buy
34,151
+10,689
+46% +$843K 0.05% 291
2025
Q3 		$1.77M Sell
23,462
-5,793
-20% -$397K 0.07% 285
2025
Q2 		$2.02M Buy
+29,255
New +$1.92M 0.08% 256
2024
Q4 		$525K Buy
11,703
+2,219
+23% +$124K 0.04% 418
2024
Q3 		$596K Sell
9,484
-2,704
-22% -$158K 0.08% 250
2024
Q2 		$720K Sell
12,188
-1,756
-13% -$110K 0.13% 160
2024
Q1 		$1.11M Buy
13,944
+1,171
+9% +$89.4K 0.22% 99
2023
Q4 		$1.01M Buy
12,773
+1,032
+9% +$73.5K 0.22% 109
2023
Q3 		$820K Buy
11,741
+2,437
+26% +$173K 0.2% 119
2023
Q2 		$643K Buy
9,304
+1,864
+25% +$133K 0.16% 151
2023
Q1 		$553K Buy
7,440
+1,760
+31% +$148K 0.15% 151
2022
Q4 		$529K Sell
5,680
-254
-4% -$24.5K 0.17% 139
2022
Q3 		$566K Sell
5,934
-566
-9% -$56K 0.21% 108
2022
Q2 		$602K Sell
6,500
-849
-12% -$82.9K 0.23% 107
2022
Q1 		$744K Sell
7,349
-405
-5% -$42.5K 0.28% 88
2021
Q4 		$800K Buy
+7,754
New +$717K 0.22% 73

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vise Technologies's CVS Position: Q2 2026 in Review

Vise Technologies increased its CVS Health (CVS) stake by 72% in Q2 2026, buying an estimated $2.21M and bringing the position to 58,892 shares worth $6.09M. The position accounts for 0.07% of the portfolio, ranked #234.

Vise Technologies first reported a position in CVS in Q4 2021 and has held it in 18 quarters since. 2,074 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Vise Technologies held 58,892 shares of CVS Health worth $6.09M as of Q2 2026.
  • Vise Technologies bought 24,741 CVS Health shares in Q2 2026, an estimated $2.21M.
  • CVS Health made up 0.07% of Vise Technologies's portfolio in Q2 2026, its #234 holding.
  • Vise Technologies first reported a position in CVS Health in Q4 2021 and has held it in 18 quarters since.
  • 2,074 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.